15.49
price up icon2.45%   0.37
after-market アフターアワーズ: 15.49
loading

なぜMyriad Genetics Inc(MYGN)の株価が下がっていますか?

2024-11-12 の取引セッション中に、Myriad Genetics Inc (MYGN) 株の 6.59% 下落を確認しました。これは通常のボラティリティやさまざまな内部および外部要因に起因する可能性がありますが、当社では状況を積極的に監視しており、できるだけ早くタイムリーな最新情報を提供することに注意してください。
2023-11-09:

Shares of Myriad Genetics (MYGN) dropped by 8.94% from $17.89 to $16.29 in the trading on Thursday, Novemeber 9, 2023. The reason why MYGN down is due to the announcement of an upsized underwritten public offering of 6,470,588 shares of common stock at $17.00 per share, with expected gross proceeds of approximately $110 million. The company intends to use the net proceeds to repay loans, settle litigation, and support working capital and general corporate purposes. The offering is managed by Goldman Sachs & Co. LLC, Morgan Stanley, and Wells Fargo Securities and is subject to customary closing conditions.

diagnostics_research LH
$239.67
price down icon 0.21%
$167.26
price down icon 1.24%
diagnostics_research WAT
$373.47
price up icon 1.35%
$140.14
price up icon 2.30%
diagnostics_research MTD
$1,217.97
price up icon 1.77%
$417.24
price down icon 0.31%
大文字化:     |  ボリューム (24 時間):